Biorasis, Inc. (Biorasis) is a privately held medical device company. The company is principally engaged in the marketing and commercialization of implantable biosensors. Biorasis uses University of Connecticut (UCONN) spin-off technology to develop a wireless, needle-implantable, miniaturized glucose sensor for real-time, continuous glucose monitoring. The principal products of the company is GlucoWizzard, which interfaces with a variety of drug-dispensing units and provides continuous glucose monitoring to achieve closed-loop insulin delivery. The company focuses on research and development (R&D) activities to develop innovative products in the areas of Diabetes and Animal care. The company operates as a subsidiary of Optoelectronic System Consulting, Inc. Biorasis is headquartered in Connecticut, the US.

Street: 
P.O. Box 158
City: 
Storrs
Postcode: 
06268
Federal State : 
United States
WebSite: 
www.bio-orasis.com
Fax: 
1-860-4293592

Company Index Score

Current Index Score Historical Index Score
  • Biorasis, Inc. currently scores 50 % in the index.
  • Biorasis, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Biorasis, Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets